Strata Critical Medical, Inc. (SRTA) stock
SRTANasdaqTransportation ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 17/3050% below fair value
$5.42−0.09 (-1.63%)
Close on Nov 16, 2026Market cap $479.49MP/E 10.6Yield –
Strata Critical Medical price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Strata Critical Medical's price to sales ratio was 2.0× on Nov 11, 2026, against 2.1× a year earlier. Over the last 5 years it ranged from 0.9× to 7.5×, with a median of 2.2×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 2.0× | −0.3 |
| 2025 | Dec 31, 2025 | 2.3× | +0.7 |
| 2024 | Dec 31, 2024 | 1.6× | −1.4 |
| 2023 | Dec 29, 2023 | 3.0× | −0.0 |
| 2022 | Dec 30, 2022 | 3.0× | −4.5 |
| 2021 | Dec 31, 2021 | 7.5× | −4.4 |
| 2020 | Dec 31, 2020 | 11.9× | – |
See a number that looks wrong?